Table II.
Summary of clinicopathological findings in UC-associated neoplasm, UC without neoplasm and normal colon.
| Characteristic | Group A1 UC associated carcinoma (n=14) | Group A2 UC associated dysplasia (n=9) | Group A UC associated neoplasm (n=23) | Group B UC without neoplasm (n=16) | Group C normal colon (n=17) | P-valuea |
|---|---|---|---|---|---|---|
| Age (year) | 55.5 (38–77) | 43 (25–68) | 48 (25–77) | 42.5 (22–77) | 69 (53–85) | 0.2414 |
| Gender | ||||||
| Male (%) | 8 (57.1) | 5 (55.6) | 13 (52.2) | 9 (56.3) | 13 (76.4) | 0.9866 |
| Female (%) | 6 (42.9) | 4 (44.4) | 10 (47.8) | 7 (43.8) | 4 (23.6) | |
| Disease duration (year) | 17.5 (0.5–35) | 15 (9–23) | 16 (0.5–35) | 6 (0.5–31) | – | 0.0067b |
| Location | ||||||
| Left side (%) | 9 (64.3) | 7 (77.8) | 16 (69.6) | – | 6 (35.3) | |
| Right side (%) | 4 (28.6) | 2 (22.2) | 6 (26.1) | – | 11 (64.7) | |
| Unknown (%) | 1 (7.1) | – | 1 (4.3) | – | – | |
| Histology | ||||||
| Well, moderate (%) | 11 (78.6) | – | – | – | ||
| Poor, mucinous (%) | 3 (21.4) | – | – | – | ||
| Tumor depth | ||||||
| pT1 (%) | 4 (28.6) | – | – | – | ||
| pT2 (%) | 5 (35.7) | – | – | – | ||
| pT3 or pT4 (%) | 5 (35.7) | – | – | – | ||
| Lymph vessel permeation | ||||||
| Negative (%) | 7 (50) | – | – | – | ||
| Positive (%) | 7 (50) | – | – | – | ||
| Venous permeation | ||||||
| Negative (%) | 11 (78.6) | – | – | – | ||
| Positive (%) | 3 (21.4) | – | – | – | ||
| Lymph node metastasis | ||||||
| Negative (%) | 9 (64.3) | – | – | – | ||
| Positive (%) | 5 (35.7) | – | – | – | ||
a
Comparison between UC associated neoplasm and UC without neoplasm.
b
Statistically significant. In the parentheses, range is described for age and disease duration, whereas percentage is described for other factors. Outside the parentheses, average years are described for age and disease duration, whereas case numbers are described for other factors.